Biotechnology · Healthcare
Board Member
Since 2019-01-01, last confirmed 2023-04-25
Cadmus C. Rich
Equibles does not estimate personal net worth.
About Cadmus C. Rich
Cadmus C. Rich was last confirmed as Board Member at Aura Biosciences, Inc. (AURA) in a filing dated April 25, 2023. Aura Biosciences, Inc. reported in an 8-K filed October 2, 2023 that Cadmus C. Rich resigned as Chief Medical Officer, effective October 16, 2023. The proxy statement of Aura Biosciences, Inc. reports total compensation of $2,398,624 for Cadmus C. Rich in fiscal 2021, including a base salary of $392,816. Disclosed compensation is on record for 2 fiscal years.
“On September 26, 2023, Cadmus Rich, M.D., notified the Company of his decision to resign from his role at the Company as an employee and Chief Medical Officer of the Company, effective as of October 16, 2023, at which time he will transition into the role of Senior Clinical Advisor until November 7, 2023 (the "Departure Date").”
Affiliation history
-
2019-01-01–2023-04-25
Last confirmed by a filing; no departure on record
-
Aura Biosciences, Inc. (AURA)
Proxy statement
Start not stated–2023-04-25
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Aura Biosciences, Inc. (AURA) | Chief Medical Officer and Head of Research & Development | $392,816 | $2,398,624 |
| 2020 | Aura Biosciences, Inc. (AURA) | Chief Medical Officer and Head of Research & Development | $377,280 | $632,366 |